Enanta Pharmaceuticals Inc (ENTA)
9.365
+0.06
(+0.59%)
USD |
NASDAQ |
Nov 22, 09:52
Enanta Pharmaceuticals Shareholders Equity (Quarterly): 148.92M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 148.92M |
March 31, 2024 | 166.11M |
December 31, 2023 | 191.88M |
September 30, 2023 | 216.74M |
June 30, 2023 | 237.82M |
March 31, 2023 | 269.38M |
December 31, 2022 | 300.84M |
September 30, 2022 | 321.33M |
June 30, 2022 | 338.02M |
March 31, 2022 | 358.58M |
December 31, 2021 | 384.38M |
September 30, 2021 | 399.43M |
June 30, 2021 | 417.85M |
March 31, 2021 | 436.03M |
December 31, 2020 | 452.00M |
September 30, 2020 | 455.58M |
June 30, 2020 | 480.56M |
March 31, 2020 | 485.99M |
December 31, 2019 | 482.29M |
September 30, 2019 | 462.49M |
June 30, 2019 | 448.10M |
March 31, 2019 | 436.21M |
December 31, 2018 | 426.84M |
September 30, 2018 | 393.68M |
June 30, 2018 | 360.90M |
Date | Value |
---|---|
March 31, 2018 | 333.40M |
December 31, 2017 | 317.58M |
September 30, 2017 | 301.68M |
June 30, 2017 | 260.87M |
March 31, 2017 | 266.01M |
December 31, 2016 | 268.17M |
September 30, 2016 | 269.94M |
June 30, 2016 | 269.01M |
March 31, 2016 | 266.42M |
December 31, 2015 | 264.28M |
September 30, 2015 | 236.16M |
June 30, 2015 | 228.28M |
March 31, 2015 | 224.22M |
December 31, 2014 | 193.71M |
September 30, 2014 | 148.65M |
June 30, 2014 | 152.95M |
March 31, 2014 | 101.72M |
December 31, 2013 | 105.58M |
September 30, 2013 | 110.47M |
June 30, 2013 | 114.41M |
March 31, 2013 | 118.38M |
December 31, 2012 | 66.22M |
September 30, 2012 | 43.93M |
June 30, 2012 | -110.25M |
September 30, 2011 | 21.95M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
148.92M
Minimum
Jun 2024
485.99M
Maximum
Mar 2020
344.41M
Average
358.58M
Median
Mar 2022
Shareholders Equity (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 1.072M |
Palatin Technologies Inc | -7.686M |
iBio Inc | 17.75M |
Theriva Biologics Inc | 24.64M |
Oragenics Inc | 3.078M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 398.82M |
Total Liabilities (Quarterly) | 249.91M |
Current Ratio | 4.922 |